Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lindstedt

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|October 3, 1992
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenaseS Lindstedt, E Holme, E A Lock, et al.
Journal of Inherited Metabolic Disease|January 1, 1996
Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC)E Pronicka, E Rowinska, Z Bentkowski, et al.
European Journal of Biochemistry|May 1, 1993
Human 4-hydroxyphenylpyruvate dioxygenase. Primary structure and chromosomal localization of the geneU Rüetschi, A Dellsén, P Sahlin, et al.
Acta Paediatrica (Oslo, Norway : 1992)|August 12, 2004
Glycerol kinase deficiency: follow-up during 20 years, genetics, biochemistry and prognosisC Hellerud, N Wramner, A Erikson, et al.
FEBS Letters|February 1, 1979
gamma-Butyrobetaine hydroxylase activity in human and ovine liver and skeletal muscle tissueG Cederblad, J Holm, G Lindstedt, et al.
Journal of Toxicology. Clinical Toxicology|July 1, 1983
Thallium poisoning--toxin elimination and therapy in three casesA Heath, J Ahlmén, B Branegård, et al.
Cytogenetics and Cell Genetics|January 1, 1995
Regional assignment of the human 4-hydroxyphenylpyruvate dioxygenase gene (HPD) to 12q24-->qter by fluorescence in situ hybridizationG Stenman, E Röijer, U Rüetschi, et al.
Clinical Chemistry|July 1, 1979
Urinary excretion of thymine and uracil in a two-year-old child with a malignant tumor of the brainG Berglund, J Greter, S Lindstedt, et al.
Journal of Inherited Metabolic Disease|July 10, 1999
NTBC as palliative treatment in chronic tyrosinaemia type IJ Ros, M A Vilaseca, N Lambruschini, et al.
Metabolism: Clinical and Experimental|December 1, 1996
Pivalic acid-induced carnitine deficiency and physical exercise in humansK Abrahamsson, B O Eriksson, E Holme, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|October 3, 1992
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenaseS Lindstedt, E Holme, E A Lock, et al.
Journal of Inherited Metabolic Disease|January 1, 1996
Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC)E Pronicka, E Rowinska, Z Bentkowski, et al.
European Journal of Biochemistry|May 1, 1993
Human 4-hydroxyphenylpyruvate dioxygenase. Primary structure and chromosomal localization of the geneU Rüetschi, A Dellsén, P Sahlin, et al.
Acta Paediatrica (Oslo, Norway : 1992)|August 12, 2004
Glycerol kinase deficiency: follow-up during 20 years, genetics, biochemistry and prognosisC Hellerud, N Wramner, A Erikson, et al.
FEBS Letters|February 1, 1979
gamma-Butyrobetaine hydroxylase activity in human and ovine liver and skeletal muscle tissueG Cederblad, J Holm, G Lindstedt, et al.
Journal of Toxicology. Clinical Toxicology|July 1, 1983
Thallium poisoning--toxin elimination and therapy in three casesA Heath, J Ahlmén, B Branegård, et al.
Cytogenetics and Cell Genetics|January 1, 1995
Regional assignment of the human 4-hydroxyphenylpyruvate dioxygenase gene (HPD) to 12q24-->qter by fluorescence in situ hybridizationG Stenman, E Röijer, U Rüetschi, et al.
Clinical Chemistry|July 1, 1979
Urinary excretion of thymine and uracil in a two-year-old child with a malignant tumor of the brainG Berglund, J Greter, S Lindstedt, et al.
Journal of Inherited Metabolic Disease|July 10, 1999
NTBC as palliative treatment in chronic tyrosinaemia type IJ Ros, M A Vilaseca, N Lambruschini, et al.
Metabolism: Clinical and Experimental|December 1, 1996
Pivalic acid-induced carnitine deficiency and physical exercise in humansK Abrahamsson, B O Eriksson, E Holme, et al.
Pageof 10